Methoxsalen 10mg Capsules

Manufacturer STRIDES PHARMA Active Ingredient Methoxsalen Capsules(meth OKS a len) Pronunciation meth-OKS-a-len
WARNING: This drug may cause very bad eye problems, age the skin, and raise the chance of skin cancer. You will be watched closely by your doctor.There are different brands and forms of this drug. Do not switch between different brands or forms of this drug without calling the doctor who ordered it. @ COMMON USES: It is used to treat psoriasis.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antipsoriatic; Photosensitizing Agent
đŸ§Ŧ
Pharmacologic Class
Psoralen
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jan 1956
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Methoxsalen is a medication taken by mouth that makes your skin more sensitive to a special type of ultraviolet light (UVA). This combination, called PUVA therapy, is used to treat severe skin conditions like psoriasis and vitiligo by slowing down skin cell growth or helping skin regain its color. It's crucial to follow your doctor's instructions carefully regarding sun exposure and eye protection.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is typically used in combination with light therapy. Take it before exposure to UV light, as directed by your doctor. It's recommended to take this medication with food or milk to help with absorption.

Storing and Disposing of Your Medication

To maintain the medication's effectiveness, store it at room temperature, protected from light. Keep it in a dry place, avoiding storage in a bathroom.

Missing a Dose

If you miss a dose, contact your doctor for guidance on what to do next. They will be able to advise you on the best course of action to get back on schedule with your medication.
💡

Lifestyle & Tips

  • **Strict Sun Protection:** For at least 24 hours after taking methoxsalen, you MUST avoid all unprotected exposure to sunlight (even through windows) and artificial UVA light. Wear protective clothing (long sleeves, pants, wide-brimmed hat) and apply broad-spectrum sunscreen (SPF 30 or higher) to all exposed skin.
  • **Eye Protection:** Wear UVA-absorbing, wrap-around sunglasses for 24 hours after taking methoxsalen, even indoors or on cloudy days, to protect your eyes from cataracts.
  • **Diet:** Take methoxsalen with food or milk to reduce nausea and stomach upset.
  • **Hydration:** Maintain good hydration.
  • **Regular Skin Checks:** Perform regular self-skin exams and have your doctor perform routine skin checks to monitor for any new or changing moles or lesions.
💊

Available Forms & Alternatives

Available Strengths:

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 0.6 mg/kg orally, 1.5 to 2 hours before UVA exposure, 2-3 times per week, with at least 48 hours between treatments. Max single dose 80 mg.
Dose Range: 0.6 - 0.6 mg

Condition-Specific Dosing:

Psoriasis: Initial dose based on patient's weight (e.g., 30-50 kg: 30 mg; 51-65 kg: 40 mg; 66-80 kg: 50 mg; 81-90 kg: 60 mg; 91-115 kg: 70 mg; >115 kg: 80 mg). Dosage may be adjusted based on patient's response and tolerance to UVA. Total UVA exposure is gradually increased.
Vitiligo: Initial dose 0.6 mg/kg orally, 1.5 to 2 hours before UVA exposure, 2-3 times per week. Treatment is continued until repigmentation or for 6-9 months. If no response, discontinue.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (safety and efficacy not established; generally not recommended due to increased risk of long-term side effects like skin cancer)
Adolescent: Not established (safety and efficacy not established; generally not recommended due to increased risk of long-term side effects like skin cancer)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Caution advised; monitor for increased photosensitivity.
Moderate: Caution advised; monitor for increased photosensitivity. Consider dose reduction.
Severe: Contraindicated or extreme caution; monitor for increased photosensitivity and toxicity.
Dialysis: Not well studied; use with extreme caution or avoid due to potential for accumulation and increased photosensitivity.

Hepatic Impairment:

Mild: Caution advised; monitor liver function and for increased photosensitivity.
Moderate: Caution advised; monitor liver function and for increased photosensitivity. Consider dose reduction.
Severe: Contraindicated or extreme caution due to extensive hepatic metabolism; monitor liver function and for increased photosensitivity and toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Methoxsalen is a psoralen derivative that, when activated by long-wave ultraviolet light (UVA, 320-400 nm), intercalates into DNA and forms covalent bonds with pyrimidine bases (primarily thymine). This leads to the formation of monofunctional and bifunctional (cross-links) adducts, inhibiting DNA synthesis and cell proliferation. In psoriasis, this action reduces the hyperproliferation of epidermal cells. In vitiligo, it stimulates melanocytes to produce melanin.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (approximately 30-50% reported, but highly variable)
Tmax: 1.5 to 3 hours
FoodEffect: Food can delay absorption and reduce peak concentrations, but may reduce gastrointestinal upset. Administering with food or milk is often recommended to mitigate nausea.

Distribution:

Vd: Not precisely quantified, but widely distributed to tissues, with preferential uptake in the epidermis.
ProteinBinding: Approximately 80% (to albumin)
CnssPenetration: Limited

Elimination:

HalfLife: 0.75 to 2.4 hours
Clearance: Not precisely quantified, but rapid
ExcretionRoute: Primarily renal (approximately 80% as metabolites within 8 hours), small amount in feces.
Unchanged: Less than 10% (renal)
âąī¸

Pharmacodynamics

OnsetOfAction: Photosensitivity begins approximately 1 hour after oral administration.
PeakEffect: Peak photosensitivity occurs 1.5 to 3 hours after oral administration.
DurationOfAction: Significant photosensitivity persists for 8-12 hours, with residual photosensitivity for up to 24 hours. Patients must avoid sun exposure for at least 24 hours after treatment.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Methoxsalen should be used only by physicians who have special competence in the diagnosis and treatment of psoriasis and who have special training and experience in photochemotherapy. Because of the risk of serious burns, methoxsalen should be used only in conjunction with a UVA light source. Patients must wear UVA-absorbing, wrap-around sunglasses for 24 hours after methoxsalen ingestion. Patients should avoid all unprotected exposure to sunlight and artificial UVA light for at least 24 hours after methoxsalen ingestion. Long-term exposure to methoxsalen and UVA light is associated with an increased risk of squamous cell carcinoma, basal cell carcinoma, and melanoma. Patients should be monitored for skin cancer throughout and after therapy. Increased risk of cataracts.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Sunburn
Changes in the color or size of a mole
Depression
A skin lump or growth
Severe dizziness or fainting
Swelling
Changes in eyesight

Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms that bother you or do not go away, contact your doctor:

Skin irritation
Itching
Redness
Upset stomach
Feeling nervous and excitable
Trouble sleeping

Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe redness, swelling, or blistering of the skin (signs of a severe burn)
  • Nausea or vomiting that is severe or persistent
  • Dizziness or headache
  • New or changing moles, freckles, or skin lesions
  • Non-healing sores
  • Changes in vision or eye discomfort
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Squamous cell cancer
+ Aphakia (absence of a lens in your eye)
A history of melanoma
If you experience sensitivity to light, which can be caused by various health conditions. If you are unsure whether you have a condition that may increase your sensitivity to light, consult your doctor or pharmacist.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help you determine whether it is safe to take this medication in conjunction with your other medications and health conditions. Never start, stop, or modify the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. As directed by your doctor, have your blood work checked and undergo eye exams to monitor your condition.

To minimize potential risks, avoid sunbathing within 24 hours before taking this drug and undergoing light therapy. Discuss any concerns with your doctor. During and for 24 hours after treatment, wear special sunglasses to protect your eyes. Additionally, apply lipstick with sunscreen to protect your lips.

Do not take this medication for a longer duration than prescribed by your doctor. Be aware that exposure to sun or UV rays can cause premature aging of the skin and increase the risk of skin cancer. You may also be more susceptible to sunburn. To protect yourself, avoid direct sunlight, sunlamps, and tanning beds, and use sunscreen regularly. Wear protective clothing and eyewear to prevent sunburn. Continue to take these precautions for as long as advised by your doctor.

Before using any other medications or products on your skin, including soaps, consult with your doctor. Note that blood clots have been reported in patients taking this medication for graft-versus-host disease, although this is not an approved use for this drug. If you have any questions or concerns, discuss them with your doctor.

If you are 65 years or older, use this medication with caution, as you may be more prone to side effects. This medication may harm an unborn baby, so if you may become pregnant, use birth control while taking this medication. If you become pregnant, notify your doctor immediately.

If you are breastfeeding, inform your doctor, as you will need to discuss any potential risks to your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe, widespread, and prolonged photosensitivity (exaggerated sunburn reaction)
  • Nausea
  • Vomiting
  • Dizziness

What to Do:

In case of overdose, immediately contact a poison control center (e.g., 1-800-222-1222) or emergency medical services. Induce vomiting if recent ingestion and patient is conscious. Keep the patient in a darkened room for at least 24 hours. Treat symptoms supportively (e.g., for severe burns).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Not explicitly contraindicated with specific drugs, but concurrent use with other photosensitizing agents should be avoided or used with extreme caution.
🔴

Major Interactions

  • Other photosensitizing agents (e.g., phenothiazines, sulfonamides, tetracyclines, thiazide diuretics, nalidixic acid, griseofulvin, some tricyclic antidepressants, some oral hypoglycemics): Increased risk of severe burns and phototoxicity.
  • CYP2A6 inhibitors (e.g., amiodarone, cimetidine, ketoconazole): May increase methoxsalen levels and enhance photosensitivity.
  • CYP1A2 inhibitors (e.g., ciprofloxacin, fluvoxamine, mexiletine): May increase methoxsalen levels and enhance photosensitivity.
🟡

Moderate Interactions

  • CYP2A6 inducers (e.g., rifampin, carbamazepine, phenobarbital): May decrease methoxsalen levels, potentially reducing efficacy.
  • CYP1A2 inducers (e.g., omeprazole, tobacco smoking): May decrease methoxsalen levels, potentially reducing efficacy.
đŸŸĸ

Minor Interactions

  • Not specifically identified as minor interactions; most interactions are related to photosensitivity or CYP metabolism.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Ophthalmologic examination (slit lamp exam)

Rationale: To rule out pre-existing lens abnormalities and establish a baseline, as methoxsalen can increase the risk of cataracts.

Timing: Prior to initiation of therapy

Liver function tests (ALT, AST, bilirubin)

Rationale: To assess hepatic function, as methoxsalen is extensively metabolized by the liver.

Timing: Prior to initiation of therapy

Complete skin examination

Rationale: To identify any suspicious lesions or skin cancers prior to treatment.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Skin examination (for erythema, blistering, new lesions)

Frequency: Before each UVA treatment and regularly throughout therapy

Target: No excessive erythema or blistering

Action Threshold: Severe erythema, blistering, or new suspicious lesions require dose adjustment, temporary cessation, or biopsy.

Ophthalmologic examination (slit lamp exam)

Frequency: Every 6-12 months during therapy and annually thereafter

Target: No new or worsening lens opacities

Action Threshold: Development of cataracts may require discontinuation.

Liver function tests (ALT, AST, bilirubin)

Frequency: Periodically (e.g., every 3-6 months) or as clinically indicated, especially in patients with pre-existing hepatic impairment.

Target: Within normal limits

Action Threshold: Significant elevation may require dose adjustment or discontinuation.

Complete blood count (CBC)

Frequency: Periodically (e.g., every 3-6 months) or as clinically indicated, though hematologic effects are rare.

Target: Within normal limits

Action Threshold: Significant abnormalities may require investigation.

đŸ‘ī¸

Symptom Monitoring

  • Nausea
  • Vomiting
  • Dizziness
  • Headache
  • Nervousness
  • Insomnia
  • Depression
  • Severe itching (pruritus)
  • Erythema (redness)
  • Blistering
  • Edema (swelling)
  • Pain or tenderness of skin
  • New skin lesions (moles, freckles, non-healing sores)
  • Changes in vision

Special Patient Groups

🤰

Pregnancy

Methoxsalen is Pregnancy Category C. While animal studies have shown some adverse effects, human data are limited. Due to its mechanism of action (DNA damage) and potential for genotoxicity, it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Many clinicians would advise against its use during pregnancy.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity and genotoxicity due to DNA-damaging effects during organogenesis.
Second Trimester: Potential for genotoxicity and long-term effects on fetal development.
Third Trimester: Potential for genotoxicity and long-term effects on fetal development.
🤱

Lactation

Methoxsalen is excreted into breast milk. Due to the potential for serious adverse reactions in the nursing infant (e.g., photosensitivity, potential for genotoxicity), a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Avoid breastfeeding during treatment and for at least 24 hours after the last dose.

Infant Risk: L4 (Potentially Hazardous) - Risk of photosensitivity, potential for genotoxicity.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Use is generally not recommended due to the increased risk of long-term side effects, particularly skin cancer, in a population with a longer life expectancy.

👴

Geriatric Use

Use with caution in elderly patients. They may be more susceptible to the adverse effects of methoxsalen and UVA therapy, including skin cancer, cataracts, and severe burns. Close monitoring of skin and eyes is essential.

Clinical Information

💎

Clinical Pearls

  • Methoxsalen therapy (PUVA) requires precise timing of drug administration relative to UVA exposure to maximize efficacy and minimize side effects.
  • Strict adherence to sun protection measures (sunglasses, protective clothing, sunscreen) for at least 24 hours post-dose is paramount to prevent severe burns and long-term complications.
  • Patients must be educated on the long-term risks, especially skin cancer and cataracts, and the importance of lifelong skin and eye surveillance.
  • Nausea is a common side effect; taking the medication with food or milk can help mitigate this.
  • The total cumulative UVA dose should be carefully monitored throughout the patient's lifetime to minimize long-term risks.
🔄

Alternative Therapies

  • Topical corticosteroids
  • Vitamin D analogs (e.g., calcipotriene)
  • Topical calcineurin inhibitors (e.g., tacrolimus, pimecrolimus)
  • Other phototherapy (e.g., Narrowband UVB)
  • Systemic agents for psoriasis (e.g., methotrexate, cyclosporine, acitretin)
  • Biologic agents for psoriasis (e.g., TNF-alpha inhibitors, IL-17 inhibitors, IL-23 inhibitors)
  • Excimer laser (for localized psoriasis/vitiligo)
  • Topical agents for vitiligo (e.g., topical corticosteroids, topical calcineurin inhibitors)
💰

Cost & Coverage

Average Cost: Varies widely, typically $100 - $500 per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Specialty/Non-preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.